Abstract
Background: Hypercalcemia is a common cl inical problem wi th an estimated pr evalence of 0.1% to 0.01% amonghospi tal ized patients and this can be ten times more in elder ly. T he a da ge, “s to nes , g r oans , b on es , an d ps y c hi a tri cov e rto nes ” i s o fte n us e d t o de s c ri b e t he s ym pto ms of hy p er p ar athy r oi di sm . Ho wev e r, 80% of el de rl y wi t h pri ma ryhyperparathyroidism present wi th asymptomatic or atypical hypercalcemia. We are classical ly taught that two mostcommon causes of hypercalcemia are mal ignancy and primary hyperparathyroidism (PHPT). Many case repor ts arepubl ished discussing the atypical presentation of hypercalcemia in elderly, meanwhi le, the review articlediscussing hypercalcemia in elderly is since 1988 (1) which also is the gold standard upon which, symptoms ofhypercalcemia in elderly are counted on and we can see that many cases are presented in a di fferent way now.This mini review includes case repor ts of atypical presentation of hypercalcemia in elderly aiming to establ ish anew sight about presentation in this age group.
Highlights
Hypercalcemia is a common clinical problem with an estimated pr evalence of 0.1% to 0.01% among hospitalized patients and this can be ten times more in elderly
The parathyroid scan showed hyperactive left upper parathyroid area. They stated “Despite the rarity of coexistence of primary hyperparathyroidism and multiple myeloma, bone marrow biopsy was obtained from our patient due to high suspicious features, i.e. weight loss, anemia, and thrombocytopenia even after confirming primary hyperparathyroidism
Hypernatremia was slowly corrected with hypotonic fluids, with improvement in his mental status over the 2 days. This was the first report of hypercalcemia associated with the use of a SLGT2 inhibitor
Summary
Hypercalcemia is a common clinical problem with an estimated pr evalence of 0.1% to 0.01% among hospitalized patients and this can be ten times more in elderly. Hypercalcemia is not a dihydroxyvitamin D level was elevated 131 pg/mL; common finding in patients with prostate cancer, but The parathyroid scan showed hyperactive left upper parathyroid area They stated “Despite the rarity of coexistence of primary hyperparathyroidism and multiple myeloma, bone marrow biopsy was obtained from our patient due to high suspicious features, i.e. weight loss, anemia, and thrombocytopenia even after confirming primary hyperparathyroidism. It revealed hypercellular marrow with decreased trilineage hematopoiesis and extensive involvement by plasma cells. The bone survey didn’t show evidence of focal lytic lesions
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Egyptian Journal of Geriatrics and Gerontology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
